Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Universe Pharmaceuticals INC (UPC)

5.09
+0.62
+(13.87%)
At close: May 7 at 4:00:01 PM EDT
5.02
-0.07
(-1.38%)
Pre-Market: 5:50:17 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Revenue
23,024.46
23,024.46
32,308.74
40,143.15
47,982.03
Cost of Revenue
16,952.56
16,952.56
21,993.60
18,251.82
22,655.85
Gross Profit
6,071.90
6,071.90
10,315.13
21,891.34
25,326.18
Operating Expense
14,091.74
14,091.74
14,281.24
28,910.78
11,736.04
Operating Income
-8,019.84
-8,019.84
-3,966.10
-7,019.44
13,590.14
Net Non Operating Interest Income Expense
-278.17
-278.17
-156.79
-162.40
-101.60
Other Income Expense
177.42
177.42
-204.54
87.53
189.94
Pretax Income
-8,120.59
-8,120.59
-4,327.43
-7,094.32
13,678.48
Tax Provision
606.70
606.70
2,253.59
815.32
2,358.53
Net Income Common Stockholders
-8,727.30
-8,727.30
-6,581.02
-7,909.64
11,319.95
Diluted NI Available to Com Stockholders
-8,727.30
-8,727.30
-6,581.02
-7,909.64
11,319.95
Basic EPS
-639.50
--
-1.11k
-1.34k
2.15k
Diluted EPS
-639.50
--
-1.11k
-1.34k
2.15k
Basic Average Shares
13.65
--
5.92
5.92
5.27
Diluted Average Shares
13.65
--
5.92
5.92
5.27
Total Operating Income as Reported
-8,019.84
-8,019.84
-3,966.10
-7,019.44
13,590.14
Total Expenses
31,044.30
31,044.30
36,274.84
47,162.60
34,391.89
Net Income from Continuing & Discontinued Operation
-8,727.30
-8,727.30
-6,581.02
-7,909.64
11,319.95
Normalized Income
-8,727.30
-8,727.30
-6,581.02
-7,909.64
11,121.37
Interest Expense
278.17
278.17
156.79
162.40
101.60
Net Interest Income
-278.17
-278.17
-156.79
-162.40
-101.60
EBIT
-7,842.42
-7,842.42
-4,170.64
-6,931.92
13,780.08
EBITDA
-7,356.69
-7,356.69
-3,661.86
-6,397.97
14,226.96
Reconciled Cost of Revenue
16,676.43
16,676.43
21,680.27
17,903.04
22,381.43
Reconciled Depreciation
485.73
485.73
508.79
533.95
446.88
Net Income from Continuing Operation Net Minority Interest
-8,727.30
-8,727.30
-6,581.02
-7,909.64
11,319.95
Total Unusual Items Excluding Goodwill
--
--
38.53
-470.48
239.55
Total Unusual Items
--
--
38.53
-470.48
239.55
Normalized EBITDA
-7,356.69
-7,356.69
-3,661.86
-6,397.97
13,987.41
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
40.96
9/30/2021 - 3/23/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PTPI Petros Pharmaceuticals, Inc.
0.1478
-24.97%
 
PRFX PainReform Ltd.
2.1200
-2.30%
 
SXTC China SXT Pharmaceuticals, Inc.
1.9000
-7.32%
 
SNOA Sonoma Pharmaceuticals, Inc.
3.0500
+0.66%
 
ZYBT Zhengye Biotechnology Holding Limited
11.52
-12.26%
 
RGC Regencell Bioscience Holdings Limited
189.99
+25.82%
 
SBFM Sunshine Biopharma, Inc.
1.2700
-3.05%
 
YCBD cbdMD, Inc.
0.9100
-11.13%
 
QNTM Quantum BioPharma Ltd.
8.41
-8.39%
 
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.2580
-5.49%